Wahl, Michael <br/><br/>
Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas.  [electronic resource] 

 -  Cancer  Dec 2017 
 - 4631-4639 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.30909  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Brain Neoplasms--drug therapy<br/>Everolimus--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Glioma--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasm Staging<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Prospective Studies<br/>Survival Rate<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors